✦ LIBER ✦

EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy

✍ Scribed by Paez, J. G.

Book ID: 118046295
Publisher: American Association for the Advancement of Science
Year: 2004
Tongue: English
Weight: 274 KB
Volume: 304
Category: Article
ISSN: 0036-8075
DOI: 10.1126/science.1099314

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

EGFR mutations predict lung-cancer respo

EGFR mutations predict lung-cancer response to gefitinib

✍ Jane Bradbury 📂 Article 📅 2004 🏛 The Lancet 🌐 English ⚖ 213 KB

EGFR regulation by microRNA in lung canc

EGFR regulation by microRNA in lung cancer: correlation with clinical response and survival to gefitinib and EGFR expression in cell lines

✍ Weiss, G. J.; Bemis, L. T.; Nakajima, E.; Sugita, M.; Birks, D. K.; Robinson, W. 📂 Article 📅 2008 🏛 Oxford University Press 🌐 English ⚖ 276 KB

The EGFR mutation and its correlation wi

The EGFR mutation and its correlation with response of gefitinib in previously treated Chinese patients with advanced non-small-cell lung cancer

✍ Zhang, X.-T. 📂 Article 📅 2005 🏛 Oxford University Press 🌐 English ⚖ 301 KB

Usefulness of EGFR mutation screening in

Usefulness of EGFR mutation screening in pleural fluid to predict the clinical outcome of gefitinib treated patients with lung cancer

✍ Junichi Soh; Shinichi Toyooka; Keisuke Aoe; Hiroaki Asano; Syuji Ichihara; Hidek 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 467 KB 👁 2 views

## Abstract The importance of epidermal growth factor receptor (EGFR) gene mutation has been recognized in nonsmall cell lung cancer (NSCLC), requiring the standardization of mutation screening system including the kind of samples. Here, we examined the __EGFR__ mutation status in 61 pleural fluid

O-123 A prospective study to correlate E

O-123 A prospective study to correlate EGFR mutations with gefitinib response in early stage NSCLC

✍ Rizvi, N.; Pao, W.; Miller, V.; Rusch, V.; Heelan, R.; Ladanyi, M.; Ginex, P.; T 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 146 KB

First-Line Gefitinib in Patients With Ad

First-Line Gefitinib in Patients With Advanced Non-Small-Cell Lung Cancer Harboring Somatic EGFR Mutations

✍ Sequist, L. V.; Martins, R. G.; Spigel, D.; Grunberg, S. M.; Spira, A.; Janne, P 📂 Article 📅 2008 🏛 American Society of Clinical Oncology 🌐 English ⚖ 228 KB